达利雷生有哪几个版本?分别多少钱?
DaliRasen is a new insomnia treatment drug and an innovative dual orexin receptor antagonist, which brings new treatment options to insomnia patients. Its version selection and price information are crucial to patients' medication decisions. This article systematically sorts out the versions of drugs currently on the market, detailed price information, and domestic accessibility status to provide patients with a comprehensive medication reference.
What versions of Dali Rayson are there?
Currently, the selection of versions on the global market is relatively limited. Understanding the characteristics of each version will help you make the right choice.
Original drug version
The original drug produced in Alschwil, Switzerland is the current mainstream version, with a specification of 50mg*20 tablets. This version has mature production technology and complete clinical data.
Regionally customized version
Some countries and regions have adjusted packaging specifications according to local regulations, but the drug ingredients and dosage remain the same. This type of version must comply with local drug regulatory standards.
The Current Situation of Generic Drugs
Currently, there are no formally approved generic versions on the market. During the patent protection period, original drugs still occupy an absolute dominant position in the market.
When selecting drugs, priority should be given to original drugs from formal channels and avoid using drugs from unknown sources.
How much do the different versions of DaliRasen cost?
Drug prices are affected by multiple factors. Understanding the pricing of each version will help you plan your treatment budget reasonably.
Original drug price
The market price of 50mg*20 tablets produced in Alschwil, Switzerland is approximately US$404, and there may be a 5%-10% price fluctuation in different sales channels.
Regional price differences
The selling price of the same product in the European and American markets is usually 8%-12% higher than that in the Asian market. In some countries, import tariffs lead to terminal price differences.
Cost considerations for purchasing drugs
In addition to the price of the drug itself, additional costs such as international shipping costs and customs duties also need to be considered. You may receive a certain discount for bulk purchases.
Be vigilant when encountering so-called generic drugs that are far below the market price. They are likely to be counterfeit products.
The marketing and medical insurance situation of DaliRasen in China
Domestic patients face certain restrictions in accessing this drug. Understanding the current situation can help formulate a reasonable medication plan.
Drug Approval Status
As of now, DaliRasen has not yet received marketing approval from the China National Medical Products Administration, and the drug cannot be provided by regular domestic hospital pharmacies.
Medical insurance coverage
Since this drug is not listed in the country, the drug is not included in any medical insurance reimbursement list, and patients need to bear the full cost of treatment out of their own pocket.
Alternative access methods
Patients in need mainly purchase through cross-border medical services or overseas pharmacies, but they must bear the risks of drug quality and transportation.
With the increase in clinical demand, it is expected that more companies will apply for the domestic marketing of this drug in the future.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)